| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | L62556GPXB |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Lymphocyte activation gene 3 protein inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
| Endometrial Neoplasms | 1 | D016889 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Biliary Tract Neoplasms | 1 | D001661 | ClinicalTrials |
| Stomach Neoplasms | 1 | D013274 | ClinicalTrials |
| Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594578 |
| FDA SRS | L62556GPXB |
CONTENTS